Resistance patterns to anti-PD-1 therapy in metastatic melanoma

Documenti analoghi

• Clinical features of acquired resistance to anti–PD-1 therapy in advanced melanoma
  di: Wang, Daniel Y., et al.
  Pubblicazione: (2017)
• Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
  di: Hugo, Willy, et al.
  Pubblicazione: (2016)
• Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
  di: Liniker, E., et al.
  Pubblicazione: (2016)
• Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of anti-PD-1 Therapies in Metastatic Melanoma
  di: Johnson, Douglas B., et al.
  Pubblicazione: (2018)
• Clinical correlates of response to anti-PD-1-based therapy in patients with metastatic melanoma
  di: Davis, Elizabeth J., et al.
  Pubblicazione: (2019)